Sen. Klobuchar calls out Rising Pharma for price-gouging an old generic drug in shortage

Min­neso­ta De­mo­c­rat Sen. Amy Klobuchar sent a let­ter on Thurs­day to Ris­ing Phar­ma­ceu­ti­cals over the com­pa­ny’s de­ci­sion to price its gener­ic drug to treat lead poi­son­ing at $32,000, which has led hos­pi­tals to no longer af­ford it or car­ry it.

While the FDA al­lowed Ris­ing to bring this poly­va­lent ion chela­tor, known as ede­tate cal­ci­um dis­odi­um, to al­le­vi­ate a short­age, Klobuchar notes that its price is “ten times the price of the im­port­ed ver­sion from France,” which is lead­ing to ac­cess is­sues.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.